SCHEMBL13140367

SCHEMBL13140367

c1ccc(-c2cncc(-c3ccccn3)n2)nc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.70
▸ CCR1 P32246 3/20 0.70
▸ CCR5 P51681 3/20 0.70
▸ CCR8 P51685 3/20 0.70
▸ LMNA P02545 3/20 0.70
▸ TP53 P04637 3/20 0.70
▸ ALOX15 P16050 3/20 0.70
▸ L3MBTL1 Q9Y468 3/20 0.70
▸ HTT P42858 2/20 0.70
▸ SMN1; SMN2 Q16637 2/20 0.70
▸ TDP1 Q9NUW8 2/20 0.70
▸ ALPL P05186 1/20 0.70
▸ HSP90AA1 P07900 1/20 0.70
▸ ALPI P09923 1/20 0.70
▸ ALPG P10696 1/20 0.70
▸ MAPK1 P28482 1/20 0.70
▸ METAP1 P53582 3/20 0.67
▸ P4HTM Q9NXG6 2/20 0.67
▸ CYP1A2 P05177 1/20 0.67
▸ POLB P06746 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23598500 0.96 KDM4E (0.78) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL23598683 0.96 KDM4E (0.78) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL19944117 0.92 KDM4E (0.59) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL27946179 0.92 KDM4E (0.59) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL3139065 0.86 KDM4E (0.54) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL17463144 0.86 KDM4E (0.54) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL13798855 0.86 KDM4E (0.54) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL3063703 0.86 KDM4E (0.54) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL30472690 0.86 KDM4E (0.54) KDM4ECCR1CCR5CCR8LMNA
Terpyridine SCHEMBL57442 0.82 KDM4E (1.00) KDM4ECCR1CCR5CCR8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8395003-B2 Metal nanoparticle-based catalytic composition that contains a nitrogen-containing ligand in an ionic liquid, process for preparation, process for hydrogenation of an olefinic feedstock IFP Energies Nouvelles (FR) 2013-03-12 — — US disclosed
US-8395003-B2 Metal nanoparticle-based catalytic composition that contains a nitrogen-containing ligand in an ionic liquid, process for preparation, process for hydrogenation of an olefinic feedstock IFP Energies Nouvelles (FR) 2013-03-12 — — US disclosed
US-8389783-B2 Process for hydrogenation of an aromatic feedstock that as catalyst uses a suspension of metal nanoparticles containing a nitrogen-containing ligand in an ionic liquid IFP Energies Nouvelles (FR) 2013-03-05 — — US disclosed
US-8389783-B2 Process for hydrogenation of an aromatic feedstock that as catalyst uses a suspension of metal nanoparticles containing a nitrogen-containing ligand in an ionic liquid IFP Energies Nouvelles (FR) 2013-03-05 — — US disclosed
US-20100228064-A1 PROCESS FOR HYDROGENATION OF AN AROMATIC FEEDSTOCK THAT AS CATALYST USES A SUSPENSION OF METAL NANOPARTICLES CONTAINING A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID IFP (FR) 2010-09-09 — — US disclosed
US-20100228064-A1 PROCESS FOR HYDROGENATION OF AN AROMATIC FEEDSTOCK THAT AS CATALYST USES A SUSPENSION OF METAL NANOPARTICLES CONTAINING A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID IFP (FR) 2010-09-09 — — US disclosed
US-20100191027-A1 METAL NANOPARTICLE-BASED CATALYTIC COMPOSITION THAT CONTAINS A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID, PROCESS FOR PREPARATION, PROCESS FOR HYDROGENATION OF AN OLEFINIC FEEDSTOCK IFP (FR) 2010-07-29 — — US disclosed
US-20100191027-A1 METAL NANOPARTICLE-BASED CATALYTIC COMPOSITION THAT CONTAINS A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID, PROCESS FOR PREPARATION, PROCESS FOR HYDROGENATION OF AN OLEFINIC FEEDSTOCK IFP (FR) 2010-07-29 — — US disclosed
WO-2008145835-A2 METHOD FOR HYDROGENATING AN AROMATIC CHARGE USING AS A CATALYST A SUSPENSION OF METAL NANOPARTICLES CONTAINING A NITROGEN LIGAND IN AN IONIC LIQUID I.F.P. (FR) 2008-12-04 — — WO disclosed
WO-2008145836-A2 CATALYTIC COMPOSITION INCLUDING METAL NANOPARTICLES CONTAINING A NITROGEN LIGAND IN AN IONIC LIQUID, METHOD FOR PREPARING SAME AND METHOD FOR HYDROGENATING AN OLEFINIC LOAD I.F.P. (FR) 2008-12-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100228064-A1 PROCESS FOR HYDROGENATION OF AN AROMATIC FEEDSTOCK THAT AS CATALYST USES A SUSPENSION OF METAL NANOPARTICLES CONTAINING A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID SET, NCL, TNK1 KDM4E 698/4885CCR1 3006/4885CCR5 3820/4885
US-20100191027-A1 METAL NANOPARTICLE-BASED CATALYTIC COMPOSITION THAT CONTAINS A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID, PROCESS FOR PREPARATION, PROCESS FOR HYDROGENATION OF AN OLEFINIC FEEDSTOCK NCL, C9, ARG1 KDM4E 2293/4885CCR1 887/4885CCR5 1116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback